Safety and Efficacy of TRPP Therapy in Glioblastoma Multiforme
Status:
Recruiting
Trial end date:
2024-07-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the safety of an innovative integrated
treatment regimen for recurrent glioblastoma , including patients with recurrent glioblastoma
multiforme.